ABSTRACT
Background Context
Purpose
Design
Patient Sample
Outcome Measure
Methods
Results
Conclusion
Key words
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Spine JournalReferences
- The risk of getting worse: predictors of deterioration after decompressive surgery for lumbar spinal stenosis: a multicenter observational study.World Neurosurg. 2015; 84: 1095-1102https://doi.org/10.1016/j.wneu.2015.05.055
- Predictors for failure after surgery for lumbar spinal stenosis, a prospective observational study.Spine J. 2023; 23: 261-270https://doi.org/10.1016/j.spinee.2022.10.010
- Predictors of patient dissatisfaction at 1 and 2 years after lumbar surgery.J Neurosurg Spine. 2019; : 1-10https://doi.org/10.3171/2019.8.SPINE19260
- Predictors of Oswestry Disability Index worsening after lumbar fusion.Orthopedics. 2013; 36: e478-e483https://doi.org/10.3928/01477447-20130327-26
- A prognostic model for failure and worsening after lumbar microdiscectomy: a multicenter study from the Norwegian Registry for Spine Surgery.Acta Neurochir (Wien). 2021; 163: 2567-2580https://doi.org/10.1007/s00701-021-04859-3
- The association between preoperative MRI findings and clinical improvement in patients included in the NORDSTEN spinal stenosis trial.Eur. Spine J. 2022; 31: 2777-2785https://doi.org/10.1007/s00586-022-07317-5
- Practical answers to frequently asked questions in minimally invasive lumbar spine surgery.Spine J. 2023; 23: 54-63https://doi.org/10.1016/j.spinee.2022.07.087
- Improvement following minimally invasive lumbar decompression in patients 80 years or older compared with younger age groups.J Neurosurg Spine. 2022; 37: 828-835https://doi.org/10.3171/2022.5.SPINE22361
- Minimum clinically important difference in lumbar spine surgery patients: a choice of methods using the Oswestry Disability Index, medical outcomes study questionnaire short form 36, and pain scales.Spine J. 2008; 8: 968-974https://doi.org/10.1016/j.spinee.2007.11.006
- Qualitative grading of severity of lumbar spinal stenosis based on the morphology of the dural sac on magnetic resonance images.Spine (Phila Pa 1976). 2010; 35: 1919-1924https://doi.org/10.1097/BRS.0b013e3181d359bd
- Magnetic resonance classification of lumbar intervertebral disc degeneration.Spine (Phila Pa 1976). 2001; 26: 1873-1878https://doi.org/10.1097/00007632-200109010-00011
- Fatty muscle degeneration in cuff ruptures. Pre- and postoperative evaluation by CT scan.Clin. Orthop. Relat. Res. 1994; : 78-83
- In search of fewer independent risk factors.Arch. Intern. Med. 2005; 165: 138-145https://doi.org/10.1001/archinte.165.2.138
- Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support.J Biomed Inform. 2009; 42: 377-381
- REDCap Consortium, The REDCap consortium: building an international community of software partners.J Biomed Inform. 2019; 95103208https://doi.org/10.1016/j.jbi.2019.103208
- The risk of "getting worse" after lumbar microdiscectomy.Eur. Spine J. 2005; 14: 49-54https://doi.org/10.1007/s00586-004-0721-5
- Who should have surgery for spinal stenosis? Treatment effect predictors in SPORT.Spine (Phila Pa 1976). 2012; 37: 1791-1802https://doi.org/10.1097/BRS.0b013e3182634b04
- Factors causing delay in discharge in patients eligible for ambulatory lumbar fusion surgery.Spine (Phila Pa 1976). 2022; 47: 1137-1144https://doi.org/10.1097/BRS.0000000000004380
- Association between muscle health and patient-reported outcomes after lumbar microdiscectomy: early results.Spine J. 2022; 22: 1677-1686https://doi.org/10.1016/j.spinee.2022.05.013
- Does pre-operative magnetic resonance imaging of the lumbar multifidus muscle predict clinical outcomes following lumbar spinal decompression for symptomatic spinal stenosis?.Eur. Spine J. 2017; 26: 2589-2597https://doi.org/10.1007/s00586-017-4986-x
- Improvement following minimally invasive transforaminal lumbar interbody fusion in patients aged 70 years or older compared with younger age groups.Neurosurg Focus. 2023; 54: E4https://doi.org/10.3171/2022.10.FOCUS22604
- Current treatment and decision-making factors leading to fusion vs decompression for one-level degenerative spondylolisthesis: survey results from members of the Lumbar Spine Research Society and Society of Minimally Invasive Spine Surgery.Spine J. 2022; 22: 1778-1787https://doi.org/10.1016/j.spinee.2022.07.095
- Minimally invasive lumbar decompression versus minimally invasive transforaminal lumbar interbody fusion for treatment of low-grade lumbar degenerative spondylolisthesis.Spine (Phila Pa 1976). 2022; 47: 1505-1514https://doi.org/10.1097/BRS.0000000000004432
- Decompression alone versus decompression and fusion for lumbar degenerative spondylolisthesis: a meta-analysis.World Neurosurg. 2018; 111: e165-e177https://doi.org/10.1016/j.wneu.2017.12.009
- Decompression with or without Fusion in Degenerative Lumbar Spondylolisthesis.N. Engl. J. Med. 2021; 385: 526-538https://doi.org/10.1056/NEJMoa2100990
- Laminectomy plus fusion versus laminectomy alone for lumbar spondylolisthesis.N. Engl. J. Med. 2016; 374: 1424-1434https://doi.org/10.1056/NEJMoa1508788
- ODI <25 denotes patient acceptable symptom state after minimally invasive lumbar spine surgery.Spine (Phila Pa 1976). 2022; https://doi.org/10.1097/BRS.0000000000004479
Shahi P, Subramanian T, Nishtha Singh, et al. NDI <21 denotes patient acceptable symptom state after degenerative cervical spine surgery. Spine. https://doi.org/10.1097/BRS.0000000000004493
- Incidence of revision surgery after decompression with vs without fusion among patients with degenerative lumbar spinal stenosis.JAMA Netw Open. 2022; 5e2223803https://doi.org/10.1001/jamanetworkopen.2022.23803
- Revision lumbar fusions have higher rates of reoperation and result in worse clinical outcomes compared to primary lumbar fusions.Spine J. 2023; 23: 105-115https://doi.org/10.1016/j.spinee.2022.08.018
Article info
Publication history
Publication stage
In Press Journal Pre-ProofFootnotes
FDA device/drug status: Not applicable.
SS: Nothing to disclose. PS: Nothing to disclose. TA: Nothing to disclose. AK: Nothing to disclose. TS: Nothing to disclose. EZ: Nothing to disclose. AK: Nothing to disclose. OM: Nothing to disclose. KA: Nothing to disclose. NS: Nothing to disclose. OT: Nothing to disclose. MK: Nothing to disclose. RK: Nothing to disclose. ES: Nothing to disclose. JD: Nothing to disclose. SQ: Royalties: Globus Medical (C); Private Investments: Tissue Differentiation (E), HS2, LLC (D); Consulting: Globus Medical (E), Stryker K2M (E); Scientific Advisory Board/Other Office: Simplify Medical, INC (B). SI: Royalties: Globus Medical (C); Private Investments: Tissue Differentiation (E), HS2, LLC (D); Consulting: Globus Medical (E), Stryker K2M (E); Scientific Advisory Board/Other Office: Simplify Medical, INC (B).